| Schedule of earnings per share, basic and diluted |
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(2,424,586 |
) |
|
$ |
(1,712,920 |
) |
|
$ |
(7,941,311 |
) |
|
$ |
(5,349,621 |
) |
Deemed dividend upon redemption of 5,221,156 shares of Series 1c convertible preferred stock |
|
$ |
- |
|
|
$ |
269,038 |
|
|
$ |
- |
|
|
$ |
269,038 |
|
|
Deemed dividend upon amendment of the terms to the
Series 1d convertible preferred stock
|
|
$ |
- |
|
|
$ |
2,293,199 |
|
|
$ |
- |
|
|
$ |
2,293,199 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to common stockholders |
|
$ |
(2,424,586 |
) |
|
$ |
(4,275,157 |
) |
|
$ |
(7,941,311 |
) |
|
$ |
(7,911,858 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted net loss per common unit/share |
|
$ |
(0.20 |
) |
|
$ |
(0.86 |
) |
|
$ |
(0.75 |
) |
|
$ |
(2.69 |
) |
Weighted-average basic and diluted common units/shares |
|
|
12,276,394 |
|
|
|
4,980,306 |
|
|
|
10,622,277 |
|
|
|
2,945,351 |
|
|
| Schedule of potentially diluted basic earnings |
|
|
As of September 30, |
|
|
|
2022 |
|
|
2021 |
|
Common stock options |
|
|
1,056,326 |
|
|
|
523,199 |
|
Common stock warrants |
|
|
6,993,813 |
|
|
|
3,091,657 |
|
Total potentially dilutive securities |
|
|
8,050,139 |
|
|
|
3,614,856 |
|
|